Biote (BTMD) Accumulated Expenses (2021 - 2026)

Biote's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 22.19% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 22.19% YoY), while the FY2025 annual figure was $5.8 million, up 2.94% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $4.7 million, down from $5.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $16.3 million in Q2 2022, with the low at $2.7 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $5.7 million (2022), against an average of $6.6 million.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses jumped 142875.0% in 2022, then tumbled 66.65% in 2023.
• Biote's Accumulated Expenses stood at $4.2 million in 2022, then surged by 43.76% to $6.1 million in 2023, then retreated by 6.97% to $5.6 million in 2024, then climbed by 2.94% to $5.8 million in 2025, then fell by 18.33% to $4.7 million in 2026.
• Business Quant data shows BTMD's Accumulated Expenses at $4.7 million in Q1 2026, $5.8 million in Q4 2025, and $11.1 million in Q3 2025.